| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 55.47B | 60.01B | 56.98B | 47.81B | 47.20B |
| Gross Profit | 11.77B | 13.71B | 9.60B | 2.47B | 3.03B |
| EBITDA | 14.38B | 27.06B | 17.32B | 17.90B | 17.80B |
| Net Income | 14.04B | 15.77B | 7.78B | 9.83B | 9.55B |
Balance Sheet | |||||
| Total Assets | 398.94B | 367.50B | 346.43B | 327.08B | 292.08B |
| Cash, Cash Equivalents and Short-Term Investments | 44.24B | 27.89B | 22.38B | 16.37B | 21.20B |
| Total Debt | 122.43B | 77.68B | 59.63B | 47.99B | 43.90B |
| Total Liabilities | 206.04B | 181.37B | 167.57B | 147.17B | 112.05B |
| Stockholders Equity | 192.22B | 185.63B | 178.34B | 179.29B | 179.71B |
Cash Flow | |||||
| Free Cash Flow | -7.72B | -925.00M | -1.14B | -12.53B | -1.17B |
| Operating Cash Flow | 11.87B | 18.49B | 11.20B | 6.76B | 7.47B |
| Investing Cash Flow | -16.57B | -20.27B | -7.72B | -1.99B | 5.97B |
| Financing Cash Flow | 20.91B | 8.50B | 1.87B | -4.57B | -14.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$22.68B | 9.75 | 5.09% | 3.48% | ― | ― | |
71 Outperform | HK$1.14B | 4.31 | 8.94% | 1.38% | 15.60% | 469.61% | |
70 Outperform | HK$5.58B | 13.83 | 1.61% | 7.48% | 2.77% | 104.40% | |
66 Neutral | HK$214.63B | 13.19 | 6.97% | 4.35% | -7.58% | -6.97% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$59.43B | 4.48 | 7.81% | 5.51% | 6.51% | 5.82% | |
56 Neutral | HK$116.92M | -33.99 | 2.17% | 8.79% | 6.83% | -91.46% |